BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang S, Yong H, He XD. Multi-omics: Opportunities for research on mechanism of type 2 diabetes mellitus. World J Diabetes 2021; 12(7): 1070-1080 [PMID: 34326955 DOI: 10.4239/wjd.v12.i7.1070]
URL: https://www.wjgnet.com/2220-3206/full/v12/i7/1070.htm
Number Citing Articles
1
Mohammed Alfaifi. Interaction between rs6446482 polymorphisms in the WFS1 gene in type 2 diabetes patientsJournal of King Saud University - Science 2022; 34(1): 101721 doi: 10.1016/j.jksus.2021.101721
2
Xue Tian, Yu Gao, Min Zhong, Mowei Kong, Lihua Zhao, Zengbin Feng, Qitian Sun, Jianqiu He, Xiaoyan Liu. The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitusBMC Cardiovascular Disorders 2022; 22(1) doi: 10.1186/s12872-022-02727-1
3
M. I. Farrim, A. Gomes, D. Milenkovic, R. Menezes. Gene expression analysis reveals diabetes-related gene signaturesHuman Genomics 2024; 18(1) doi: 10.1186/s40246-024-00582-z
4
Vladimir V. Chrishtop, Artur Y. Prilepskii, Varvara G. Nikonorova, Vladimir A. Mironov. Nanosafety vs. nanotoxicology: adequate animal models for testing in vivo toxicity of nanoparticlesToxicology 2021; 462: 152952 doi: 10.1016/j.tox.2021.152952
5
Jinghan Xu, Chunli Piao, Yue Qu, Tianjiao Liu, Yuting Peng, Qi Li, Xiaohua Zhao, Pei Li, Xuemin Wu, Yawen Fan, Binqin Chen, Jie Yang. Efficacy and mechanism of Jiedu Tongluo Tiaogan Formula in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease: Study protocol for a parallel-armed, randomized controlled trialFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.924021
6
Enmin Ding, Fuchang Deng, Jianlong Fang, Tiantian Li, Minmin Hou, Juan Liu, Ke Miao, Wenyan Yan, Ke Fang, Wanying Shi, Yuanzheng Fu, Yuanyuan Liu, Haoran Dong, Li Dong, Changming Ding, Xiaohui Liu, Krystal J. Godri Pollitt, John S. Ji, Yali Shi, Yaqi Cai, Song Tang, Xiaoming Shi. Association between Organophosphate Ester Exposure and Insulin Resistance with Glycometabolic Disorders among Older Chinese Adults 60–69 Years of Age: Evidence from the China BAPE StudyEnvironmental Health Perspectives 2023; 131(4) doi: 10.1289/EHP11896
7
Omar Ramos-Lopez. Genotype-based precision nutrition strategies for the prediction and clinical management of type 2 diabetes mellitusWorld Journal of Diabetes 2024; 15(2): 142-153 doi: 10.4239/wjd.v15.i2.142
8
Javier Suárez, Federico Boem. Technology-driven surrogates and the perils of epistemic misalignment: an analysis in contemporary microbiome scienceSynthese 2022; 200(6) doi: 10.1007/s11229-022-03912-7
9
Xin Zhang, Erwin Kupczyk, Philippe Schmitt-Kopplin, Constanze Mueller. Current and future approaches for in vitro hit discovery in diabetes mellitusDrug Discovery Today 2022; 27(10): 103331 doi: 10.1016/j.drudis.2022.07.016
10
Md. Numan Islam, Md. Golam Rabby, Md. Munnaf Hossen, Md. Mostafa Kamal, Md. Ashrafuzzaman Zahid, Md. Syduzzaman, Md. Mahmudul Hasan, Bertrand Blondeau. In silico functional and pathway analysis of risk genes and SNPs for type 2 diabetes in Asian populationPLOS ONE 2022; 17(8): e0268826 doi: 10.1371/journal.pone.0268826
11
Golnoosh Mahjoob, Yasin Ahmadi, Huda Fatima rajani, Nafiseh khanbabaei, Sakhavat Abolhasani. Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patientsJournal of Clinical Laboratory Analysis 2022; 36(5) doi: 10.1002/jcla.24380
12
Ousman Bajinka, Yurong Tan, Alansana Darboe, Isabella Gloria Ighaede-Edwards, Khalid A. Abdelhalim. The gut microbiota pathway mechanisms of diabetesAMB Express 2023; 13(1) doi: 10.1186/s13568-023-01520-3
13
Duygu Ağagündüz, Mehmet Arif Icer, Ozge Yesildemir, Tevfik Koçak, Emine Kocyigit, Raffaele Capasso. The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitusJournal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04088-5